Gastroenterology
Volume 132, Issue 3 , Pages 944-954 , March 2007

Nonmyeloablative Stem Cell Therapy Enhances Microcirculation and Tissue Regeneration in Murine Inflammatory Bowel Disease

  • Philipe N. Khalil

      Affiliations

    • Department of Surgery, Klinikum Innenstadt, Ludwig-Maximilians-Universität of München, Munich, Germany
    • Corresponding Author InformationAddress requests for reprints to: Philipe N. Khalil, MD, Department of Surgery, Klinikum Innenstadt, Ludwig-Maximilians-Universität München, Nuβbaumstraβe 20, 80336 Munich, Germany. fax: (49) 89-5160-4722.
    • ,
  • Véronique Weiler

      Affiliations

    • Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany
    • ,
  • Peter J. Nelson

      Affiliations

    • Department of Clinical Biochemistry, Medizinische Poliklinik, Ludwig-Maximilians-Universität München, Munich, Germany
    • ,
  • Maurice N. Khalil

      Affiliations

    • Department of Surgery, Klinikum Innenstadt, Ludwig-Maximilians-Universität of München, Munich, Germany
    • ,
  • Sabine Moosmann

      Affiliations

    • Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany
    • ,
  • Wolf E. Mutschler

      Affiliations

    • Department of Surgery, Klinikum Innenstadt, Ludwig-Maximilians-Universität of München, Munich, Germany
    • ,
  • Matthias Siebeck

      Affiliations

    • Department of Surgery, Klinikum Innenstadt, Ludwig-Maximilians-Universität of München, Munich, Germany
    • ,
  • Ralf Huss

      Affiliations

    • Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany

Received 17 July 2006 ,Accepted 16 November 2006.

References 

  1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature. 2003;3:521–533
  2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429
  3. Boismenu R, Chen Y. Insights from mouse models of colitis. J Leukocyte Biol. 2000;67:267–278
  4. Elson CO, Sator RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–1367
  5. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002;20:495–549
  6. Neurath MF, Finotto S, Glimcher LH. The role of TH1/TH2 polarization in mucosal immunity. Nat Med. 2002;8:567–573
  7. Hanauer SB. Inflammatory bowel disease. N Engl J Med. 1996;334:841–848
  8. Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet. 2002;359:331–340
  9. Shanahan F. Crohn’s disease. Lancet. 2002;359:62–69
  10. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702–712
  11. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434–438
  12. MacDermott RP, Sanderson IR, Reinecker HC. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 1998;4:54–67
  13. Mangi AA, Noiseux N, Kong H, He H, Rezvani M, Ingwall JS, et al. Mesenchymal stem cells modified with AKT prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003;9:1195–1201
  14. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocaedium. Nature. 2001;410:701–705
  15. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653–660
  16. Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation. 2001;8:283–301
  17. Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in infammatory bowel disease: loss of nitric oxide-mediated vasodilatation. Gastroenterology. 2003;125:58–69
  18. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-β in Crohn’s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol. 2001;96:822–828
  19. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inahgaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702
  20. Lange C, Kaltz C, Thalmeier K, Kolb HJ, Huss R. Long-term hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1 low, c-kit+ stem cell line. J Hematother Stem Cell Res. 1999;8:335–342
  21. Huss R, Heil M, Moosmann S, Ziegelhoeffer T, Sagebiel S, Seliger C, et al. Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL(+) multipotent adult progenitor cell clones from peripheral blood. J Vasc Res. 2004;41:422–431
  22. Cuzzocrea S, McDonald MC, Mazzon E, Mota-Filipe H, Centorrino T, Terranova ML, et al. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut. 2001;48:478–488
  23. Wallace JL, Keenan CM, Gale D, Shoupe TS. Exacerbation of experimental colitis by non-steroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology. 1992;102:18–27
  24. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238–249
  25. Onderdonk AB, Hermos JA, Bartlett JG. The role of the intestinal microflora in experimental colitis. Am J Clin Nutr. 1977;30:1819–1825
  26. Huss R, Renner-Muller I, Buchstaller A. Adult scl+/+ murine hemangioblasts persist in allogenic mutant blastocysts but fail to rescue the scl−/− phenotype. Stem Cells Dev. 2005;14:402–407
  27. Huss R. Perspectives on the morphology and biology of CD34−negative stem cells. J Hematother Stem Cell Res. 2000;9:783–793
  28. Von Luttichau I, Notohamiprodjo M, Wechselberger A, Peters C, Henger A, Seliger C, et al. Human adult CD34− progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev. 2005;14:329–336
  29. Huss R. Isolation of primary and immortalized CD34− hematopoietic and mesenchymal stem cells from various sources. Stem Cells. 2000;18:1–9
  30. Conrad C, Huss R. Adult stem cell lines in regenerative medicine and reconstructive surgery. J Surg Res. 2005;124:201–208
  31. Huss R, Hong DS, McSweeney PA, Hoy CA, Deeg HJ. Diffentiation of canine bone marrow cells with hematopoietic characteristics from adherent stromal cell precursor. Proc Natl Acad Sci U S A. 1995;92:748–752
  32. Bamba S, Lee CY, Brittan M, Preston SL, Direkze NC, Alison MR, et al. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol. 2006;209:265–273
  33. Brittan M, Chance V, Elia G, Poulsom R, Alison MR, MacDonald TT, et al. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesisan myofibroblasts. Gastroenterology. 2005;128:1984–1995
  34. Komori M, Tsuji S, Tsujii M, Murata H, Iijima H, Yasumaru M, et al. Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Rep Reg. 2005;13:109–118
  35. Barkholt L, Löfberg R. Resetting the immune system in refractory Crohn’s disease: is autologous hematopoietic stem cell transplantation the way forward?. Gastroenterology. 2005;128:786–789
  36. Folwaczny C, Glas J, Folwaczny M, Török HP. Autologous hematopoietic stem cell transplantation in refractory Crohn’s disease: a feasible therapeutic approach?. Gastroenterology. 2005;128:2180
  37. Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology. 2005;128:552–563
  38. Dielman LA, Pena AS, Meuwissen SGM, Van Rees EP. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol. 1997;32:99–104
  39. Pizarro TT, Arseneau KO, Bamias G, Cominelli F. Mouse models for the study of Crohn’s disease. Trends Mol Med. 2003;9:218–222
  40. Conrad C, Gottgens B, Kinston S, Ellwart J, Huss R. GATA-trancription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(−)CD105(+) mesenchymal cell line. Exp Hematol. 2002;30:887–895
  41. Scholz D, Cai WJ, Schaper W. Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis. 2001;4:247–257
  42. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res. 2004;94:230–238
  43. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol. 2002;34:775–787
  44. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med. 2002;8:841–849
  45. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T, Martin S, van den Heuvel J, et al. VEGF-1-selective VEGF homologue PlGF is arteriogenic (Evidence for a monocyte-mediated mechanism). Circ Res. 2003;92:378–385
  46. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831–840
  47. Gering M, Rodaway AR, Gottgens B, Patient RK, Green AR. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 1998;17:4029–4045
  48. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Amano K, Iba O, et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol. 2002;22:1804–1810
  49. Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P, et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation. 2003;71:28–41

PII: S0016-5085(06)02679-5

doi: 10.1053/j.gastro.2006.12.029

Gastroenterology
Volume 132, Issue 3 , Pages 944-954 , March 2007

Article Tools

* Image Usage & Resolution